Bianca Gustafson, Senior Director of Program Management at Cryoport Systems, shares insight on bridging clinical proof of concept and commercial readiness, covering supply chain risks and global distribution challenges.
Plan Commercial Logistics Early
Decisions made in clinical supply, from packaging to carriers, shape commercial performance. Early planning avoids costly changes later.
Managing Global Distribution Risk
Temperature control, customs, and regional regulatory requirements need defined contingency plans and clear ownership.
Structured Program Management
Cross-functional governance and clear milestones keep manufacturing, logistics and clinical teams aligned through scale-up.
About This White Paper
This white paper is published by Cryoport Systems and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.